このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

AddLife マネジメント

マネジメント基準チェック /24

AddLife'sの CEO はFredrik Dalborgで、 Jan2022年に任命され、の在任期間は 2.42年です。の年間総報酬はSEK 8.70Mで、 56.8%給与と43.2%のボーナス（会社の株式とオプションを含む）で構成されています。は、会社の株式の0.026%を直接所有しており、その価値は€ 345.98K 。経営陣と取締役会の平均在任期間はそれぞれ0.8年と8.8年です。

主要情報

Fredrik Dalborg

最高経営責任者

SEK 8.7m

報酬総額

CEO給与比率	56.8%
CEO在任期間	2.4yrs
CEOの所有権	0.03%
経営陣の平均在職期間	less than a year
取締役会の平均在任期間	8.8yrs

経営陣の近況

Recent updates

CEO報酬分析

AddLife の収益と比較して、Fredrik Dalborg の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Mar 31 2024	n/a	n/a	SEK 78m
Dec 31 2023	SEK 9m	SEK 5m	SEK 190m
Sep 30 2023	n/a	n/a	SEK 293m
Jun 30 2023	n/a	n/a	SEK 388m
Mar 31 2023	n/a	n/a	SEK 429m
Dec 31 2022	SEK 6m	SEK 2m	SEK 480m

報酬と市場: Fredrikの総報酬 ($USD 837.75K ) は、 German市場 ($USD 1.49M ) の同様の規模の企業の平均を下回っています。

報酬と収益: Fredrikの報酬は 20% 以上増加しましたが、会社の収益は過去 1 年間で 20% 以上減少しました。

CEO（最高経営責任者

Fredrik Dalborg (52 yo)

2.4yrs

在職期間

SEK 8,704,000

報酬

Mr. Fredrik Dalborg serves as President & Chief Executive Officer at AddLife AB (publ) since 2022. Mr. Dalborg served as Managing Director for North America at Xvivo Perfusion AB (publ) since December 15,...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Fredrik Dalborg	President & CEO	2.4yrs	SEK 8.70m	0.026% SEK 348.2k
Christina Rubenhag	Chief Financial Officer	2.4yrs	データなし	0.0053% SEK 70.8k
Julie O'Leary	Investor Relations Manager	less than a year	データなし	データなし
Christian Karlsson	Head of Business Development	3.4yrs	データなし	データなし
Per Wahlstedt	Head of Business Control	2.4yrs	データなし	データなし
Timmy Rosendal	Head of Sustainability	less than a year	データなし	データなし
Ioana Dragan	Head of Financial Control	less than a year	データなし	データなし
Jamilah Wass	Group Financial Controller	no data	データなし	データなし
Nichlas Essner	Group Business Controller	less than a year	データなし	データなし
Malin Lindh	Group Business Controller	less than a year	データなし	データなし

0.8yrs

平均在職期間

経験豊富な経営陣: 1AD1の経営陣は経験豊富とはみなされません ( 0.8年の平均在職年数)。これは新しいチームを示唆しています。

取締役

名称	ポジション	在職期間	報酬	所有権
Birgit Norinder	Independent Director	8.8yrs	SEK 350.00k	0.010% SEK 137.8k
Eva Elmstedt	Independent Director	3.1yrs	SEK 350.00k	0.0041% SEK 54.5k
Johan Sjo	Independent Chairman	9.3yrs	SEK 700.00k	0.14% SEK 1.8m
Håkan Roos	Independent Director	8.9yrs	SEK 350.00k	4.75% SEK 63.1m
Eva Nilsagard	Independent Director	8.5yrs	SEK 500.00k	0.0046% SEK 60.7k
Stefan Hedelius	Independent Director	8.8yrs	SEK 350.00k	0.024% SEK 321.9k

8.8yrs

平均在職期間

62yo

平均年齢

経験豊富なボード: 1AD1の取締役会は経験豊富であると考えられます ( 8.8年の平均在任期間)。

AddLife マネジメント

マネジメント 基準チェック /24

主要情報

経営陣の近況

Insufficient new directors

Independent Director recently bought €2.8m worth of stock

AddLife AB (publ), Annual General Meeting, May 08, 2024

Independent Director recently bought €1.0m worth of stock

President & CEO recently bought €12k worth of stock

President & CEO recently bought €10.0k worth of stock

Recent updates

AddLife AB (publ) to Report Q1, 2025 Results on Apr 25, 2025

Insufficient new directors

AddLife AB (publ) Approves Dividend, Payable on 16 May 2024

First quarter 2024 earnings released: EPS: kr0.51 (vs kr1.43 in 1Q 2023)

AddLife AB (publ) to Report Fiscal Year 2024 Results on Feb 05, 2025

Independent Director recently bought €2.8m worth of stock

AddLife AB (publ) to Report Fiscal Year 2023 Results on Apr 05, 2024

Dividend of kr0.50 announced

Full year 2023 earnings released: EPS: kr1.56 (vs kr3.94 in FY 2022)

AddLife AB (publ) to Report Q3, 2024 Results on Oct 23, 2024

Investor sentiment improves as stock rises 26%

Third quarter 2023 earnings released

AddLife AB (publ) to Report First Half, 2024 Results on Jul 15, 2024

Now 22% undervalued after recent price drop

AddLife AB (publ), Annual General Meeting, May 08, 2024

New major risk - Share price stability

Investor sentiment deteriorates as stock falls 33%

New minor risk - Dividend sustainability

Second quarter 2023 earnings released: EPS: kr0.27 (vs kr0.61 in 2Q 2022)

Investor sentiment deteriorates as stock falls 15%

Independent Director recently bought €1.0m worth of stock

Addlife AB (Publ) Declares Dividend

Investor sentiment improves as stock rises 22%

Upcoming dividend of kr1.20 per share at 1.0% yield

First quarter 2023 earnings released

President & CEO recently bought €12k worth of stock

President & CEO recently bought €10.0k worth of stock

Full year 2022 earnings released: EPS: kr3.94 (vs kr6.02 in FY 2021)

AddLife AB (publ) Proposes Dividend for the Year Ended December 31, 2022

Håkan Roos acquired a 0.246285% stake in AddLife AB (publ) for SEK 30 million.

Third quarter 2022 earnings released

AddLife AB (publ) to Report First Half, 2023 Results on Jul 14, 2023

AddLife AB (publ) to Report Q1, 2023 Results on Apr 26, 2023

Now 22% undervalued after recent price drop

Second quarter 2022 earnings released

Now 20% undervalued after recent price drop

Investor sentiment deteriorated over the past week

CFO & Business Area Manager of Medtech recently sold €808k worth of stock

Addlife AB (Publ) Approves Dividend, Payable on 12 May 2022

Upcoming dividend of kr2.00 per share

AddLife AB (publ) Appoints Fredrik Dalborg as President

Full year 2021 earnings released: EPS: kr6.02 (vs kr4.62 in FY 2020)

AddLife AB (publ) (OM: ALIF B) acquired O'Flynn Medical Limited.

Addlife AB (Publ) Proposes Dividend, Payable on 12 May 2022

Investor sentiment improved over the past week

AddLife AB (publ) (OM:ALIF B) completed the acqusitions of Telia Health Monitoring.

President & CEO recently bought €552k worth of stock

Addlife AB (Publ) Proposes Dividend

Addlife AB (Publ) Announces Step Down of Kristina Willgård as Chief Executive Officer

AddLife AB (publ) (OM:ALIF B) completed the acquisition of MBA Incorporado S.A from Alantra Private Equity.

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire MBA Incorporado S.A from Alantra Private Equity for approximately €110 million.

AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire Telia Health Monitoring.

Investor sentiment deteriorated over the past week

Beijing AddLife AB (publ) (OM:ALIF B) acquired Camanio AB from Brighter AB (publ) (OM:BRIG) for SEK 65 million.

President & CEO recently sold €3.2m worth of stock

Investor sentiment improved over the past week

Third quarter 2021 earnings released

Independent Chairman recently sold €1.1m worth of stock

AddLife AB (publ) (OM:ALIF B) acquired Bio-Connect BV.

Investor sentiment improved over the past week

Independent Chairman recently sold €689k worth of stock

Second quarter 2021 earnings released: EPS kr1.46 (vs kr1.07 in 2Q 2020)

Investor sentiment improved over the past week

Chief Financial Officer recently sold €1.4m worth of stock

Independent Director has left the company

AddLife AB (publ) Approves Dividend, Payable on 12 May 2021

First quarter 2021 earnings released

マネジメント基準チェック /24